Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial Fibrillation. Journal of Pharmaceutical Negative Results [Internet]. 2023 Jan. 1 [cited 2026 Jun. 8];:1221-7. Available from: https://pnrjournal.com/index.php/home/article/view/7523